The trademark application CYTOPREME was filed by Cytotheryx, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 1, 2021, and it was registered by office on December 9, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and address of the trademark registration was recorded on October 2, 2023. Appointment and Replacement of representative of the trademark registration was recorded on June 6, 2024.
Goods And Services
The mark was filed in class 1 with following description of goods:
Cell lines, other than for medical or veterinary purposes
Cell lines and human cells for scientific research, laboratory research, medical research and cell culture
Human cell lines, namely, human hepatocytes for use in research
Pooled donor cell lines, other than for medical or veterinary purposes
Cell lines for use in research
Cell lines for use in toxicology, adme and dmpk studies
Cell lines for use in hepatitis and malaria research.